What You Should Know:
– A recent survey by the Prevent Cancer Foundation reveals a concerning trend among Gen Z (ages 21-27) – they are significantly lagging behind older generations in getting routine cancer screenings.
–…
Continue Reading
What You Should Know:
– Reimagine Care the nation’s leading provider of on-demand cancer care, and Memorial Hermann Health System one of the largest not-for-profit health systems in Texas, are excited to announce a multi-year expansion of…
Continue Reading
Hospital network Alfred Health in Victoria has onboarded and digitised the health records of their cancer patients to Oracle’s EHR solution for oncology. WHY IT MATTERS
Alfred Health finds significant value in Oracle Oncology in helping…
Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical
The landscape of cancer treatment has continued to evolve, and the annual ASCO Meetings often set the stage for “what’s next in cancer care.” The…
Continue Reading
What You Should Know: – Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute…
Continue Reading
Robots with magnetic skin and movement that mimics creeping vine plants could transform cancer diagnosis and treatment, according to a study by University of Leeds.
The “magnetic vine robots” developed by Leeds researchers grow as…
What You Should Know: – Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including…
Continue Reading
Introduction
The radiotherapy market is experiencing significant growth, driven by an increasing incidence of cancer and advancements in technology. According to a recent analysis by Mordor Intelligence, the market is expected to expand substantially from…
What You Should Know:
– GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions, is excited to introduce MIM Symphony HDR Prostate to support high dose-rate (HDR) brachytherapy.
– This innovative solution aims…
Continue Reading
What You Should Know:
– Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP…
Continue Reading
